Search

Your search keyword '"Stehlik J"' showing total 1,176 results

Search Constraints

Start Over You searched for: Author "Stehlik J" Remove constraint Author: "Stehlik J"
1,176 results on '"Stehlik J"'

Search Results

151. Cardiac Reverse Remodeling and Recovery in Dilated Cardiomyopathy Medication-Naive Patients Requiring Durable Left Ventricular Assist Device Support

156. Predictors of Favorable Outcome in Patients Bridged to Transplant with Temporary Mechanical Circulatory Support Devices

161. Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease

162. Treatment of Anemia with Darbepoetin Alfa in Systolic Heart Failure

164. A Novel Predictive Risk Score for Gastrointestinal Bleed Following Implantation of Continuous Flow Left Ventricular Assist Device

165. Impact of a Novel Shared Healthcare Delivery Model in Remotely Located Patients with Left Ventricular Assist Devices

166. Advanced Failing Hearts Have a Wide Range of Fibrosis Including Overlap with Nonfailing Hearts

172. Feasibility and Effectiveness of a Shock Team Approach in Refractory Cardiogenic Shock: Preliminary Results

173. Outcome and Primary Endpoint Results From a Prospective Multi-center Study of Myocardial Recovery Using LVADs: Remission from Stage D Heart Failure (RESTAGE-HF)

174. Association of Comorbid Conditions and Quality of Life in Ambulatory Heart Failure Patients: A Report From REVIVAL

176. Identifying Ambulatory Advanced Heart Failure Patients at High Risk for Death, LVAD or Transplant at 1-year: How Did the REVIVAL Eligibility Criteria Perform?

177. The ISHLT 2017 Updated DCD Registry Report

179. Donor Mechanism of Death (MOD) and Interstitial Fibrin (INTFIB) as Predictors of Outcome After Heart Transplantation

184. Ustekinumab as induction and maintenance therapy for Crohn's disease

187. Outcomes of Asian-Americans Undergoing Left Ventricular Assist Device Implantations as a Bridge to Transplant or Destination Therapy: An INTERMACS Analysis

189. Comparison of Long-Term Survival Outcomes in Recipients of Lungs from Donation After Circulatory Death (DCD) and Donation After Brain Death (DBD)

190. Slower Gait Speed as a Measure of Frailty Tracks with INTERMACS Profiles, Quality of Life and Predicted Mortality in Ambulatory Patients with Advanced Heart Failure: A Report from the REVIVAL Registry

191. Markers of Intermediate-Term Risk After Heart Transplant - Results of the CTOT-18 Study

193. Extended Donation After Circulatory Death (DCD) Cat 3 Lung Donor Agonal and Post-Mortem Warm Ischemic Times (WIT) Do Not Affect Early Mortality

194. Excellent Outcomes After Heart Transplantation in Stable, Highly-Sensitized Heart Transplant Recipients Using a Wait and Match Strategy

195. Unique Characteristics of Allograft Microvasculature in Patients with Severe Symptomatic Cardiac Allograft Vasculopathy

Catalog

Books, media, physical & digital resources